Bactobio Ltd
Research and experimental development on biotechnology · London
ActiveUnited KingdomIncorporated 2020Private Limited Company
Financial position
Accounts to 2025-12-31 · GBP · Company accounts
Net assets
£2,460,782
Cash
£1,060,808
Turnover
—
Profit / loss
—
Current assets
£2,465,034
Creditors < 1 year
—
Equity
£2,460,782
Average employees
51
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2025-12-317 months · Company | 2025-05-3112 months · Company | 2024-05-3112 months · Company | 2023-05-3112 months · Company | 2022-05-3112 months | 2021-05-3112 months |
|---|---|---|---|---|---|---|
| Balance sheet | ||||||
| Net assets | £2,460,782 | £4,832,172 | £2,747,713 | £6,144,992 | — | — |
| Equity | £2,460,782 | £4,832,172 | £2,747,713 | £6,144,992 | £2,043,121 | £634,247 |
| Assets | ||||||
| Fixed assets | — | — | — | £623,848 | £307,937 | £140,068 |
| Property, plant & equipment | £558,047 | £861,999 | £807,798 | £601,360 | £285,449 | £117,580 |
| Current assets | £2,465,034 | £4,620,151 | £2,432,855 | £5,824,053 | £1,971,801 | £531,094 |
| Cash at bank | £1,060,808 | £2,098,065 | £1,791,408 | £5,176,893 | £1,309,754 | £298,449 |
| Debtors | £1,404,226 | £2,522,086 | £641,447 | £647,160 | £662,047 | £232,645 |
| Liabilities | ||||||
| Creditors within one year | — | — | £447,999 | £302,909 | £236,617 | £36,915 |
| Creditors after one year | — | — | £44,941 | £0 | — | — |
| Net current assets | £2,006,909 | £4,141,316 | £1,984,856 | £5,521,144 | £1,735,184 | £494,179 |
| Assets less current liabilities | £2,564,956 | £5,003,315 | £2,792,654 | £6,144,992 | £2,043,121 | £634,247 |
| People & pay | ||||||
| Average employees | 51 | 50 | 0.42 | 30 | 19 | 4 |
| Source evidence | View filing | View filing | View filing | View filing | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesNo charges available in our records.
Scaleup signal
OECD growth threshold met
23% employee CAGR